Omega Healthcare Investors, Inc.

NYSE:OHI Stock Report

Mkt Cap: US$7.1b

We’ve recently updated our valuation analysis.

Omega Healthcare Investors Valuation

Is OHI undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for OHI?

Other financial metrics that can be useful for relative valuation.

OHI key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue12.4x
Enterprise Value/EBITDA14.6x
PEG Ratio-2.1x

Price to Earnings Ratio vs Peers

How does OHI's PE Ratio compare to its peers?

The above table shows the PE ratio for OHI vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPEEstimated GrowthMarket Cap
Peer Average37.6x
HR Healthcare Realty Trust
85.4x-15.6%US$8.2b
MPW Medical Properties Trust
6.2x-17.3%US$7.7b
DOC Physicians Realty Trust
30.1x-13.0%US$3.8b
PEAK Healthpeak Properties
28.7x-25.3%US$15.0b
OHI Omega Healthcare Investors
16.6x-7.9%US$7.1b

Price-To-Earnings vs Peers: OHI is good value based on its Price-To-Earnings Ratio (16.6x) compared to the peer average (37.6x).


Price to Earnings Ratio vs Industry

How does OHI's PE Ratio compare vs other companies in the US REITs Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a5.3%
n/an/an/a

Price-To-Earnings vs Industry: OHI is good value based on its Price-To-Earnings Ratio (16.6x) compared to the US REITs industry average (27.3x)


Price to Earnings Ratio vs Fair Ratio

What is OHI's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

OHI PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio16.6x
Fair PE Ratio22.8x

Price-To-Earnings vs Fair Ratio: OHI is good value based on its Price-To-Earnings Ratio (16.6x) compared to the estimated Fair Price-To-Earnings Ratio (22.8x).


Share Price vs Fair Value

What is the Fair Price of OHI when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: OHI ($29.44) is trading below our estimate of fair value ($42.42)

Significantly Below Fair Value: OHI is trading below fair value by more than 20%.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst OHI forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$29.44
US$29.77
+1.1%
10.6%US$36.00US$25.00n/a13
Jan ’24US$27.95
US$32.23
+15.3%
6.5%US$36.00US$28.00n/a13
Dec ’23US$29.99
US$32.77
+9.3%
6.4%US$36.00US$28.00n/a13
Nov ’23US$31.87
US$32.62
+2.3%
7.9%US$36.00US$28.00n/a13
Oct ’23US$29.49
US$33.29
+12.9%
6.9%US$36.00US$29.00n/a14
Sep ’23US$32.45
US$33.00
+1.7%
7.3%US$36.00US$29.00n/a14
Aug ’23US$31.38
US$30.36
-3.3%
6.2%US$33.00US$27.00n/a14
Jul ’23US$28.79
US$30.13
+4.7%
6.5%US$33.00US$27.00n/a15
Jun ’23US$29.53
US$30.77
+4.2%
7.8%US$36.00US$27.00n/a13
May ’23US$25.48
US$30.43
+19.4%
9.6%US$36.00US$25.00n/a14
Apr ’23US$31.77
US$30.85
-2.9%
8.5%US$36.00US$27.00n/a13
Mar ’23US$27.53
US$31.86
+15.7%
10.4%US$38.00US$27.00n/a14
Feb ’23US$30.99
US$33.29
+7.4%
8.8%US$38.00US$29.00US$29.4414
Jan ’23US$29.59
US$33.92
+14.6%
10.4%US$39.00US$29.00US$27.9513
Dec ’22US$27.47
US$34.38
+25.2%
9.8%US$39.00US$29.00US$29.9913
Nov ’22US$30.11
US$36.54
+21.3%
6.0%US$39.00US$30.00US$31.8713
Oct ’22US$30.34
US$37.62
+24.0%
6.6%US$43.00US$33.00US$29.4913
Sep ’22US$33.79
US$38.79
+14.8%
7.0%US$43.00US$33.00US$32.4514
Aug ’22US$36.28
US$40.43
+11.4%
5.1%US$44.00US$37.00US$31.3814
Jul ’22US$36.47
US$40.14
+10.1%
4.7%US$43.00US$37.00US$28.7914
Jun ’22US$37.51
US$39.85
+6.2%
5.6%US$43.00US$36.00US$29.5313
May ’22US$38.00
US$39.77
+4.7%
5.5%US$43.00US$36.00US$25.4813
Apr ’22US$38.46
US$39.77
+3.4%
5.5%US$43.00US$36.00US$31.7713
Mar ’22US$37.83
US$39.62
+4.7%
5.5%US$43.00US$36.00US$27.5313
Feb ’22US$37.13
US$37.92
+2.1%
8.2%US$43.00US$31.00US$30.9913

Analyst Forecast: Target price is less than 20% higher than the current share price.


Discover undervalued companies